Description
Why It’s Done:
The HER2/neu by FISH test is performed to:
• Determine if a breast cancer or gastric cancer is HER2-positive.
• Help guide treatment decisions, especially regarding targeted therapies such as trastuzumab (Herceptin), pertuzumab, or lapatinib.
• Confirm ambiguous or borderline results from a HER2 IHC test (e.g., IHC score of 2+).
• Evaluate prognosis, as HER2-positive cancers tend to be more aggressive but may respond well to targeted therapy.
Preparation:
• No special preparation is required from the patient.
• The test is performed on a sample of tumor tissue, usually obtained through:
o Biopsy
o Surgical removal of the tumor
• The tissue is then processed in a lab for analysis using FISH.


